Abstract
We investigated the number of articles listed in MEDLINE every five years from 1976 regarding gentamicin therapy and endolymphatic sac surgery for the treatment of Meniere's disease. Gentamicin therapy is now the most used therapeutic modality for the treatment of Meniere's disease although the actual number of patients treated is unknown. It should be possible to optimize methods to deliver gentamicin for each patient, including drug amount, administration frequency, and the use of special devices such as microcatheters. Because commercially available gentamicin contains three major components, C1, C2 and C1a, the differences in vestibular and cochlear toxicity among the three components should be investigated to search for more selective vestibulotoxicity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
